Amiloidózis: vizsgálatok itt: Norvégia
8 trials · From ClinicalTrials.gov, checked 2026. november 11.. Ask the study team whether a trial fits you.
- 3. fázisTaking peopleMAGNITUDE: A Phase 3 Study of NTLA-2001 in Participants With Transthyretin Amyloidosis With Cardiomyopathy (ATTR-CM)
- Where
- Oslo
- Életkor
- 18 év to 90 év
- People
- 1200 worldwide
- Run by
- Intellia Therapeutics
See details and how to joinNCT06128629 · EU 2023-507220-23-00 - 3. fázisCsak meghívásosA Study to Evaluate Vutrisiran in Patients With Transthyretin Amyloidosis With Cardiomyopathy
- Where
- Oslo
- Életkor
- 18 év and over
- People
- 700 worldwide
- Run by
- Alnylam Pharmaceuticals
See details and how to joinNCT06679946 - 3. fázisTaking peopleTRITON-CM: A Study to Evaluate Nucresiran in Patients With Transthyretin Amyloidosis With Cardiomyopathy
- Where
- Aalesund, Loerenskog
- Életkor
- 18 év to 85 év
- People
- 1750 worldwide
- Run by
- Alnylam Pharmaceuticals
See details and how to joinNCT07052903 · EU 2024-519917-72-00 - 4. fázisTaking peopleA Study to Learn More About the Change in the Blood Levels of Transthyretin When Participants With Transthyretin Amyloidosis With Cardiomyopathy Switch From Tafamidis to Acoramidis
- Where
- Oslo
- Életkor
- 18 év to 90 év
- People
- 50 worldwide
- Run by
- Bayer
See details and how to joinNCT07298044 · EU 2025-521831-35-00 - No phaseTaking peopleA Study to Learn About the Use of Acoramidis in Patients With a Heart Condition Called Transthyretin Amyloid Cardiomyopathy (ATTR-CM) in a Real-world Setting
- Where
- Multiple Locations
- Életkor
- 18 év and over
- People
- 2000 worldwide
- Run by
- Bayer
See details and how to joinNCT07235462 - 3. fázisNot yet taking people in NorvégiaAn Open-Label Study to Evaluate the Long-Term Safety and Efficacy of ALXN2220 in Adults With Transthyretin Amyloid Cardiomyopathy
- Where
- Lorenskog, Oslo, Trondheim
- People
- 1180 worldwide
- Run by
- Alexion Pharmaceuticals, Inc.
See details and how to joinNCT07789483 · EU 2026-526755-57-00 - No phaseTaking peopleATTR Cardiac Amyloidosis in a Selected Population
- Where
- Ålesund
- Életkor
- 50 év and over
- People
- 180
- Run by
- Helse Møre og Romsdal HF
See details and how to joinNCT06458374 - No phaseTaking peopleThe Norwegian Immunotherapy in Multiple Myeloma Study
- Where
- Ålesund, Arendal, Bærum, Bergen, Bodø, Drammen, Førde, Gjøvik, Haugesund, Kristiansand, Kristiansund, Levanger, Molde, Nordbyhagen, Oslo, Skien, Stavanger, Tønsberg, Tromsø, Trondheim, Volda
- Életkor
- 18 év and over
- People
- 400
- Run by
- St. Olavs Hospital
See details and how to joinNCT06855121